Indicator | Measure | Criterion met/expected change | Source, Year |
---|---|---|---|
Information, advice and support from the multidisciplinary team given to the patients (and with their consent, to the carers) | (%) | Given to all the patients/relatives/care givers | SIGN 64, 2002 |
Use of referral protocols (to neurovascular clinics and admission to stroke unit) | (%) | Given to all the patients | NHS QIS (CSBS-PPI 2002) Clinical Standards, 2004; CHD/Stroke Task Force, 2001; SPREAD, 2005 |
Use of clinical protocols (at least 5 of the following) | (%) | Given to all the patients | CHD/Stroke Task Force, 2001; CSBS 2002; Antiplatelet Trialists' Collaboration, 1994; SIGN 13, 1997; European Atrial Fibrillation Trial, 1993; Hebert PR, 1997; SIGN 14, 1997; Antithrombotic Trialists' Collaboration, 1998 |
- Stroke treatment/management protocols | Â | Â | Â |
- Antiplatelet/anticoagulant protocol | Â | Â | Â |
- Diabetes treatment protocol | Â | Â | Â |
- Atrial fibrillation therapy protocol | Â | Â | Â |
- Blood pressure lowering protocol | Â | Â | Â |
- Cholesterol lowering protocol | Â | Â | Â |
- Suspected carotid stenosis protocol | Â | Â | Â |
- Smoking cessation protocol | Â | Â | Â |
Use of (local) admission to social services protocols | (%) | Given to all patients | Report to the Dept. of Health, 2000 |
Use of CT/MRI brain scan within 48 hours from admission | (%) | 80% | SIGN 14, 1997; Wardlaw JM, 2003 |
Aspirin treatment within 48 hours from admission | (%) | Given to all patients | Gubitz G (Cochrane 2003) |
Swallow screen test on day of admission | (%) | Given to all patients | SIGN 20, 1997 |
Blood pressure assessment | (%) | Given to all patients | Progress, 2001; NHS QIS (CSBS 2002); Clinical Standards, 2004 |
ECG/ECD within 24 hours from admission | (%) | Given to all patients | SIGN 13, 1997 |
Continuous monitoring within 48 hours from admission (see parameters below) | (%) | Differences in rates | SIGN 13, 1997; New Zealand Guidelines Group, 2003; Canadian Stroke Network and the Heart and Stroke Foundation of Canada, 2006 |
- Blood pressure | Â | Â | Â |
- Glycaemia | Â | Â | Â |
- Electrolitemia | Â | Â | Â |
- Breath | Â | Â | Â |
Before discharge total assessment (see parameters below) | (%) | Given to all patients | MRC/BHF Heart Protection Study, 2002, 2003; SIGN 24, 1998 |
- Tobacco smoke | Â | Â | Â |
- Lipemia | Â | Â | Â |
- Glycaemia | Â | Â | Â |
Use of discharge plan (and communication) | (%) | Given to all the patients/relatives/care givers | SIGN 24, 1998 |
Use of SIGN guidelines-based discharge plan | (%) | Â | SIGN 24, 1998 |
Use of discharge summary and information (information pack) | (%) | Â | RCPE, Consensus Panel, Nov 2000; SIGN 65, 2003 |